RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal
Lisa Ann Kachnic, Kathryn A Winter, Robert J. Myerson et al. · International Journal of Radiation Oncology*Biology*Physics · 2012
Cited by 621 works. doi:10.1016/j.ijrobp.2012.09.023
Authors
- Lisa Ann Kachnic
- Kathryn A Winter
- Robert J. Myerson
- Michael D E Goodyear
- J. Willins
- Jacqueline Esthappan
- Michael G. Haddock
- Marvin Z. Rotman
- Parag Jitendra Parikh
- Howard P. Safran
- Christopher G. Willett
References
- Optimal two-stage designs for phase II clinical trials
- Combined therapy for cancer of the anal canal
- Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.
- Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin
- Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.
- Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin
- Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal
- Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: A Radiation Therapy Oncology Group Consensus Panel Contouring Atlas
- Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.
- Intensity-modulated radiation therapy (IMRT) in the treatment of anal cancer: Toxicity and clinical outcome